Search Results - Sara Volpe
- Showing 1 - 3 results of 3
-
1
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observ... by Alfredo Vozza, Sara Volpe, Carlo Custodero, Valentina Colaianni, Valentina Lavarra, Domenico Triggiani, Lucilla Crudele, Alessandro Bergamasco, Gianfranco Antonica, Cosimo Tortorella, Giuseppina Piazzolla
Published in Journal of Diabetes Research (2025-01-01)Get full text
Article -
2
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study by Sara Volpe, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Domenico Triggiani, Lucilla Crudele, Vincenzo Triggiani, Carlo Sabbà, Giovanni De Pergola, Giuseppina Piazzolla
Published in Frontiers in Endocrinology (2023-09-01)Get full text
Article -
3
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study by Alfredo Vozza, Domenico Triggiani, Margherita Fanelli, Giuseppe Lisco, Deborah Coletto, Carlo Custodero, Sara Volpe, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Rosselia Maggipinto, Andrea Portacci, Cosimo Tortorella, Antonio Moschetta, Giuseppina Piazzolla
Published in Frontiers in Endocrinology (2025-09-01)Get full text
Article
